Psychedelic Bulletin #143: Trademark Filing Reveals Potential Brand Name for MDMA; DEA “Open to Considering” Special Registration for Controlled Substances via Telemedicine; Professional Practice Guidelines for PAT; Sage’s Zuranolone Rejection

This author acknowledges the definition of ‘psychedelic’ is contentious and that MDMA is an empathogen, or entactogen. We’re not counting ketamine here, either.The press release read, “prior trials of DMX-1002”.